The new insights on osteosarcome could, with time, lead to better treatment options and outcomes for patients through more ...

A SPANISH research team has identified the key cause of a rare cancer primarily affecting children.  Osteosarcoma, a type of ...

A major driver of the bone cancer osteosarcoma has been discovered by researchers from UCL, EMBL EBI and the Royal National Orthopaedic Hospital, providing insights that could help to predict cancer ...

OST-HER2 led to significant 12-month event-free survival and demonstrated favorable overall survival trends at 1 and 2 years ...

New research has identified a novel mechanism driving osteosarcoma – an aggressive paediatric bone cancer – providing ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 ...

A new study reveals a mutation mechanism in osteosarcoma, promising advances in treatment and prognosis for this challenging ...

Bone pain. Joint pain. Bone swelling. These are symptoms that about 1,000 people in the United States begin to feel each year ...

New research, published in the journal Cell, solves the mystery of what drives the genomic rearrangements causing the aggressive development and evolution of osteosarcoma tumours. By analysing the ...

Early evidence suggests that certain epigenetic states and gene expression profiles could indicate whether a tumor is likely to metastasize, even at early stages before traditional methods can detect ...

The U.S. FDA is to temper the alert it put out in November 2023 pointing to a potential risk of CAR T therapies causing de novo malignancies. “There was this issue of possible safety concerns with T ...